Navigare Ventures Research
Investment Thesis
Navigare Ventures is an early-stage investor in science-driven, deep tech companies at the frontier of science and technology. Founded in 2021 and based in Stockholm, Navigare is a wholly-owned subsidiary of Wallenberg Investments AB and invests permanent capital rather than raising third-party fund vehicles. The firm's stated philosophy is 'we only invest in companies we understand' - Navigare expects founders to explain the underlying science and technology thoroughly, and it evaluates opportunities based on scientific merit as much as financial projections. Realized returns flow back to the Wallenberg Foundations, which in turn fund Swedish basic research, creating a closed loop between venture returns and academic research funding.
Sector Focus
Navigare organizes its thesis around three to four core deep tech themes:
- Advanced computing and quantum technologies
- Synthetic biology and bio innovation
- Advanced materials and nanotechnology
- Data-driven life science
In practice the portfolio spans diagnostics and multi-cancer detection (Elypta, Rarity Bioscience), spatial proteomics and life-science tools (Pixelgen), cell-free biomanufacturing (EnginZyme), energy-efficient semiconductor processes (AlixLabs, SweGaN, TeraSi), quantum sensing (Adamant Quanta), AI-driven robotics (Intuicell), industrial AI/manufacturing quality (Interspectral), agtech (Arevo), and water-recovery technology (Retein).
Stage Focus
Navigare invests at Seed and Series A, describing itself as a long-term investor seeking 'deep and lasting partnerships with founders' rather than a quick-turn financial investor. Round sizes across the announced portfolio range from roughly SEK 7-40 million (~$0.7M-$4M) at seed to EUR 12-75 million at growth/Series A-type rounds, though Navigare's own check size within a syndicate is not publicly disclosed.
Lead Tendency
Navigare frequently leads or co-leads rounds - press releases describe it as leading the Rarity Bioscience EUR 6.5M round, the Interspectral raise, the SweGaN EUR 12M equity raise, and co-leading Profundus (with Gobia Enterprises) and the Peafowl Plasmonics seed (with Industrifonden).
Recent Activity
Navigare has been consistently active since 2022, averaging several announced investments per year. Confirmed activity in the trailing 12 months (per the firm's own news page) includes a $2.2M round for Epigenica (June 2025), a 7.8M SEK round for ProteomEdge (May 2025), the unveiling of portfolio company Intuicell's robotic dog 'Luna' (March 2025), and a new investment in Nordic Forestry Automation (January 2025). Third-party trackers (Tracxn) report Navigare made roughly four new investments in 2026, including Solinide Photonics and a follow-on in Pixelgen, though these are not yet corroborated by a Navigare press release with a citable primary source.
Portfolio Highlights
Navigare's 'Venture Portfolio' (later-stage, named companies) includes 11 companies: Elypta, Arevo, ScandiBio, Pixelgen, Rarity Bioscience, EnginZyme, AlixLabs, Intuicell, Profundus, Interspectral, and SweGaN. Its earlier-stage 'Discovery Portfolio' lists 17 additional companies including Epigenica, ProteomEdge, Basic Genomics, Nordic Forestry Automation, Scaleout Systems, Ligna Energy, Amylonix, Retein, Adamant Quanta, TeraSi, and Zytox Therapeutics. No exits were disclosed on the firm's site.
Team
- David Sonnek, CEO and Investment Manager - 20+ years in VC, PhD in Atomic Physics, focuses on physics, ICT, and quantum technologies
- Jenny Lindgren, Portfolio Manager/CFO - prior Altor private equity and Nordic VC/PE due diligence
- Alex Basu, CIO and Investment Manager - deep tech at the engineering-biology intersection, prior Industrifonden and Alder
- Salla Franzén, Investment Manager - mathematics/engineering intersection, PhD in Mathematics
- Diana Henningsson, Investment Manager - management consulting background
- Pontus de Laval, Senior Expert - former Saab CTO, 14 years as a radar engineer
- Elin Almstedt, Principal - life sciences, prior Sobi and Karolinska Institutet Innovations
- Michelle Nilsson, Coordinator/Executive Assistant
- Lilian Wikström, Senior Expert - former CEO of Karolinska Institutet Innovations
- Gustav Notander, Investment Manager - runs the Navigare First early-stage program, prior Almi Invest
- Fredrik Dahl, Industrial Advisor - serial life science entrepreneur with exits to PerkinElmer and Agilent
Decision Process
With a CEO plus five named Investment Managers/CIO covering distinct scientific domains (physics/ICT, biology, mathematics, life sciences), decisions appear to run through a partnership model rather than a single decision-maker. The firm explicitly declines unprepared meetings, requiring pitch materials, a website, and scientific papers up front.
Founder Preferences
Navigare looks for experienced entrepreneurial teams that combine scientific excellence with strong business acumen, with a unique offering, proven commercial potential through real customer engagement, and a use of capital to scale R&D, production, marketing, and sales.
Geographic Focus
Navigare is based in Stockholm and currently prioritizes ventures based in the Nordics or with a strong connection to industry or research in the region.